CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05882747
NCT05882747N/ACompleted
CompareCT.gov

The Results of Surgery for Renal Cell Carcinoma Metastases in the Pancreas

Rigshospitalet, Denmark·observational·Posted May 31, 2023·Updated Nov 28, 2023

In Brief

An observational study for Surgery. Completed, enrolled 25 participants.

Detailed Summary

Patients' outcome was studied after surgery for renal cell carcinoma. The primary outcome was overall survival and desease free survival. Secondary outcame was complications to surgery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 31, 2023
Enrollment StartJan 1, 2011
Primary CompletionDec 31, 2021
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 11 yearsPosted 3.1 years ago